Covid-19: financial reports and dividend policy
30 March 2020

With the deadline for listed companies to approve their financial statements fast approaching, issuers and operators have various questions before them in the face of the Covid-19 emergency. The foremost is how to reconcile the requirements under special legislation, especially regarding terms/deadlines, with the need for flexibility that issuers seek in this turbulent and uncertain time.

In response, the European Securities and Markets Authority has issued a public statement asking national authorities to adopt a generally tolerant approach to companies that publish their financial reports after the deadlines set by the Transparency Directive.

Our Capital Markets Focus Team, in collaboration with the Covid-19 Task Force, has prepared a summary of these policies. If you would like a copy, just email